Interviews

Fredrika Klarén

2025-03-28

Consumers today need hope—they need to see that choosing a more sustainable option does not mean compromising on design, performance, or convenience.

Antony Mattessich

CEO

Amphista Therapeutics

2025-03-27

Amphista Therapeutics is a biotechnology company specializing in targeted protein degradation to develop novel treatments for diseases, with a focus on oncology.

Alberto Benegas Lynch Jr.

Economist

Argentina

2025-03-27

Argentina has long suffered from economic stagnation due to interventionist policies. The current administration represents a break from that tradition, aiming to dismantle structures that have hindered economic freedom. However, political challenges and institutional resistance remain significant obstacles. For liberalism to endure, it must not only implement economic reforms but also foster a cultural shift towards valuing individual responsibility and market-driven solutions.

Gordon C. McCauley

President & CEO

adMare BioInnovations

2025-03-26

adMare BioInnovations is a Canadian life sciences organization focused on advancing biotech innovation by providing resources, expertise, infrastructure, and support to emerging companies in the sector.

Pat Smallcombe

CEO

Metagenics

2025-03-26

Metagenics has a unique story. Founded in 1983, it was one of the pioneers of functional medicine in the United States. It is built on credible science and exceptional product quality - vital for delivering great healthcare.

Michael Mahaz

SVP Global Business Units, Healthcare

Jabil

2025-03-26

Jabil is a global engineering, supply chain, and manufacturing solutions provider. Its healthcare division specializes in the design, development, and production of medical devices, orthopedic, diagnostics, pharmaceutical development and delivery systems, and digital health technologies for healthcare and life sciences companies.

Tim Herbert

Chairman & CEO

Inspire Medical Systems

2025-03-25

Inspire Medical Systems, Inc., is a medical technology company dedicated to redefining the standard of care for obstructive sleep apnea (OSA).

Marc Dunoyer

CEO

Alexion

2025-03-21

Our priority is to allocate resources effectively. If a drug does not show a strong enough potential benefit, we prefer to discontinue it early rather than invest in late-stage trials with a high risk of failure. Our goal is not just to bring a new drug to market, but to ensure it provides a meaningful benefit and improvement over existing options, if any exist. Strategic portfolio management is essential in rare disease research, where development costs are high and patient populations are small.

Abigail Buckwalter

CEO

Nestlé Health Science U.S.

2025-03-21

I strongly believe that to lead effectively CEOs must also be part cultural anthropologists—constantly observing, engaging, and understanding the industry and consumer behavior. It's not just about the what, but more importantly, the why behind it.

Julie Boyster

CMO, & Lisa Barnes, Vice President of Research and Development and Regulatory

LifeVantage

2025-03-20

A growing trend on Instagram is the use of broadcast channels, where influencers engage smaller, segmented audiences on specific topics, such as their supplement regimen or wellness journey. This targeted approach fosters deeper engagement and allows influencers to connect meaningfully with their followers.

Pagina 18 din 174